Breaking down the fort: Combatting clinical biofilms

Antibiotic-resistant Acinetobacter baumanii are forming protective layers called biofilms.

Treating bacterial infections can be challenging, even more so when they build a fort. These forts, or ‘biofilms’, form on living and non-living surfaces, such as heart valves, and protect bacteria from immune responses and antibiotics. This can lead to serious, chronic conditions, for instance an infection of the heart’s lining (endocarditis), relapsing infections and increased mortality. To help combat […]

Read More…

Unlocking the chemical secrets of microbial conversations

Dr Matt Traxler of the University of California, Berkeley, is changing the way we study microbes. Gone are the days of thinking about a single species in a pure culture in the lab – Traxler and his team of graduate students and postdocs are developing a version of mass spectrometry which promises to allow single microbial cells, and their interactions […]

Read More…

A new class of antibiotic drugs

a science article about Dr McMaster’s research which focuses on metabolic regulation with an eye toward the development of therapies for unmet medical needs in the infectious and inherited disease spaces.

Finding new classes of antibiotic drugs could not only save human lives, but also greatly reduce the healthcare costs related to tackling bacteria resistant to currently available drugs. Professor Chris McMaster, director of the Cheminformatics Drug Discovery Lab at Dalhousie University in Halifax, Canada, is developing a new class of antibiotics, while trying to overcome the many challenges associated with […]

Read More…